Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)

NCT05742841 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT05742841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05742841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 4
Overall status
Completed
Start date
March 8, 2023
Completion date
July 15, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lipid disorder